CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...
The South African on MSN
IEB class of 2025 achieves 98.31% pass rate
The Independent Examinations Board (IEB) has achieved an overall pass rate of 98.31% for the 2025 matric exams.
KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...
New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
There is no increased risk for colorectal cancer, advanced-stage cancer, or advanced adenoma when colonoscopy is delayed up to 24 months after a positive FIT result.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...
A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...
Freenome, an early cancer detection company developing blood-based screening tests, today is reporting the improved clinical performance of an updated version of its SimpleScreen™ CRC test. In data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback